UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K/A

(Amendment No. 1)

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2019

[ ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission file number: 000-54457

GENERAL CANNABIS CORP

(Exact name of registrant as specified in its charter)


COLORADO

 

90-1072649

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

6565 E. Evans Avenue

Denver, Colorado  80224

(Address of principal executive offices)


Registrant's telephone number, including area code: (303) 759-1300


Securities registered pursuant to Section 12(b) of the Act:  None.


Securities registered pursuant to Section 12(g) of the Act:  None.


Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No þ

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No þ

Indicate by check mark whether the registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulations S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. þ

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.


Large accelerated filer 

 

Accelerated filer 

 

Non-accelerated filer

 þ

Smaller reporting company 

 þ

Emerging growth company

 

 

 


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act): Yes o No þ


The aggregate market value of the voting stock held by non-affiliates of the registrant, based upon the closing sale price of the registrant’s common stock on June 30, 2019, was $31,638,715.


As of May 5, 2020, the Registrant had 40,281,881 issued and outstanding shares of common stock.






EXPLANATORY NOTE


This Amendment No. 1 on Form 10-K/A (this “Amendment”) to the Annual Report on Form 10-K of General Cannabis Corp (the “Company”) for the fiscal year ended December 31, 2019 (the “Original Form 10-K”), as filed with the Securities and Exchange Commission (the “SEC”) on May 14, 2020, is being filed solely to amend the Original Form 10-K to include, prior to Part I of the Original Form 10-K, the disclosure set forth below under “Reliance on Securities and Exchange Commission Order” to disclose that the Original Form 10-K was filed in reliance upon the 45-day extension provided by the SEC’s order, dated March 4, 2020, Granting Exemptions from Specified Provisions of the Exchange Act and Certain Rules Thereunder (Release No. 34-88318), as modified pursuant to the SEC’s order, dated March 25, 2020, Modifying Exemptions from the Reporting and Proxy Delivery Requirements for Public Companies (Release No. 34-88465) (collectively, the “Order”), under Section 36 of the Securities Echange Act of 1934, as amended (the “Exchange Act”), and to amend and restate Item 7 of the Original Form 10-K in its entirety to correct a typographical error that mistakenly stated cost and expenses under the heading “Results of Operations—Consolidated Results”as (12,258,035) when it should have stated (12,528,035).  In addition, as required by Rule 12b-15 of the Exchange Act, Part IV, Item 15 has also been amended to include updated certifications of the Company’s principal executive officer and principal financial officer are included as exhibits hereto.


Except as expressly set forth above, this Amendment does not, and does not purport to, amend, update or restate the information in any other item of the Original Form 10-K, or the exhibits thereto, or reflect any events that have occurred after the filing of the Orginal Form 10-K.  Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and the Company’s other filings with the SEC subsequent to the filing of the Original Form 10-K.


RELIANCE ON SECURITIES AND EXCHANGE COMMISSION ORDER


This Annual Report on Form 10-K of General Cannabis Corp (the “Company”) for the fiscal year ended December 31, 2019 (this “Form 10-K”) is being filed in reliance upon the 45-day extension provided by the order of the Securities and Exchange Commission (the “SEC”), dated March 4, 2020, Granting Exemptions from Specified Provisions of the Exchange Act and Certain Rules Thereunder (Release No. 34-88318), as modified pursuant to the SEC’s order, dated March 25, 2020, Modifying Exemptions from the Reporting and Proxy Delivery Requirements for Public Companies (Release No. 34-88465) (collectively, the “Order”), under Section 36 of the Securities Echange Act of 1934, as amended (the “Exchange Act”).  On March 30, 2020, the Company filed a  Current Report on Form 8-K with the SEC stating its intent to rely on the Order to delay the filing of this Form 10-K until no later than May 14, 2020, which is 45 days from the original filing deadline of March 30, 2020, because the Company was unble to meet the original filing deadline due to circumstances relating to the novel coronavirus, COVID-19.  The Company’s operations and business have been disrupted due to the unprecedented conditions and travel restrictions surrounding the COVID-19 pandemic spreading throughout the United States.  These disruptions have resulted in limited access to the Company’s facilities and have interfered with management’s ability to work with its independent accountants, professional advisors and support staff in order to complete the Company’s financial statements and related disclosures that are included in this Form 10-K by the original filing deadline.  Accordingly, this Form 10-K is being filed on May 14, 2020 in reliance on the Order. 


PART II


ITEM 7.     MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


This Management’s Discussion and Analysis (“MD&A”) is intended to provide an understanding of our financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year.  This discussion should be read in conjunction with the Consolidated Financial Statements and related notes in Item 8 of this Report.


Cautionary Statement Regarding Forward-looking Statements


Our MD&A contains forward-looking statements that discuss, among other things, future expectations and projections regarding future developments, operations and financial condition.  All forward-looking statements are based on management’s existing beliefs about present and future events outside of management’s control and on assumptions that may prove to be incorrect.  If any underlying assumptions prove incorrect, our actual results may vary materially from those anticipated, estimated, projected or intended.  We undertake no obligation to publicly update or revise any forward-looking statements to reflect actual results, changes in expectations or events or circumstances after the date of this Report is filed.


2




Going Concern


The consolidated financial statements included elsewhere in this Form 10-K, have been prepared on a going concern basis, which assumes we will be able to realize our assets and discharge our liabilities in the normal course of business for the foreseeable future.  Our cash of approximately $224,994 as of December 31, 2019 is not sufficient to absorb our operating losses and retire our debt of $2,330,351 and other obligations as they come due.  The warrants associated with this debt, if exercised, would provide sufficient funds to retire the debt; however, there is no guarantee that these warrants will be exercised.  Our ability to continue as a going concern is dependent upon our generating profitable operations in the future and / or obtaining the necessary financing to meet our obligations and repay our liabilities arising from normal business operations when they come due. Management believes that (a) we will be successful obtaining additional capital and (b) actions presently being taken to further implement our business plan and generate additional revenues provide opportunity for the Company to continue as a going concern.  While we believe in the viability of our strategy to generate additional revenues and our ability to raise additional funds, there can be no assurances to that effect.  Accordingly, there is substantial doubt about our ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.


Results of Operations

 

As of December 31, 2019, we made the strategic decision to cease operations of Chiefton and STOA Wellness.  All operations were abandoned in January 2020.  Separately, we classified Iron Protection Group as held for sale as of December 31, 2019, in which the contracts of the Colorado division were sold in January 2020 and the remaining contracts in California have been abandoned.  The completed and planned divestiture of these non-core businesses has changed the way in which we evaluate performance and allocate resources.  As a result, during the year ended December 31, 2019, we revised our business segments, consistent with our management of the business and internal financial reporting structure.  


The following tables set forth, for the periods indicated, statements of operations data.  The tables and the discussion below should be read in conjunction with the accompanying consolidated financial statements and the notes thereto appearing in Item 8 in this Report.


Consolidated Results


 

 

Year ended December 31,

 

 

 

Percent

 

 

2019

 

2018

 

Change

 

Change

Revenues

$

3,666,346

$

1,737,256

$

1,929,090

 

111%

Costs and expenses

 

(12,528,035)

 

(12,308,231)

 

(219,804)

 

2%

Other expense

 

(1,925,411)

 

(5,564,335)

 

3,638,924

 

(65)%

Net loss from continuing operations

 

(10,787,100)

 

(16,135,310)

 

5,348,210

 

(33)%

Loss from discontinued operations

 

(1,675,539)

 

(838,448)

 

(837,091)

 

100%

Net loss

$

(12,462,639)

$

(16,973,758)

$

4,511,119

 

(27)%


The following discussion of our results of operations relates to our continuing operations.  See Note 3 to the consolidated financial statements for information concerning discontinued operations.


Revenues


Revenue increased for our Operations and Investments Segments, offset by a loss from discontinued operations.  See Segment discussions below for further details.


Costs and expenses


 

 

Year ended December 31,

 

 

 

Percent

 

 

2019

 

2018

 

Change

 

Change

Cost of service revenues

$

858,714

$

1,055,593

$

(196,879)

 

(19)%

Cost of goods sold

 

1,608,386

 

400,097

 

1,208,289

 

302%

Selling, general and administrative

 

4,379,800

 

3,411,724

 

968,076

 

28%

Share-based compensation

 

3,966,621

 

5,995,007

 

(2,028,386)

 

(34)%

Professional fees

 

1,598,818

 

1,383,367

 

215,451

 

16%

Depreciation and amortization

 

115,696

 

62,443

 

53,253

 

85%

 

$

12,528,035

$

12,308,231

$

219,804

 

2%


Cost of service revenues typically fluctuates with the changes in revenue for our Operations Segments.  Cost of goods sold varies with changes in product sales, including an increase in products sold by our Operations Segment, which have smaller margins. See Segment discussions below for further details.


3




Selling, general and administrative expense increased in 2019 primarily due to increases for (a) salaries; (b) premiums for liability, and directors and officer’s insurance; (c) computer and internet costs; and (d) marketing costs.


Share-based compensation included the following:


 

 

Year ended December 31,

 

 

 

Percent

 

 

2019

 

2018

 

Change

 

Change

Employee awards

$

3,040,497

$

3,626,271

$

(585,774)

 

(16)%

Consulting awards

 

85,683

 

306,466

 

(220,783)

 

(72)%

Feinsod Agreement

 

840,441

 

2,062,270

 

(1,221,829)

 

(59)%

 

$

3,966,621

$

5,995,007

$

(2,028,386)

 

(34)%


Employee awards are issued under our 2014 Equity Incentive Plan, which was approved by shareholders on June 26, 2015, and expense varies primarily due to the number of stock options granted and the share price on the date of grant.  Consulting awards are granted to third parties in lieu of cash for services provided.  The Feinsod Agreement expense represents equity-based compensation pursuant to agreements with Michael Feinsod for serving as the Executive Chairman of our Board.  


Professional fees consist primarily of accounting and legal expenses and have increased slightly from 2018 due primarily to the cost of raising debt.


Depreciation and amortization expense increased due to normal depreciation expense for our ERP system.


Other Expense


 

 

Year ended December 31,

 

 

 

Percent

 

 

2019

 

2018

 

Change

 

Change

Amortization of debt discount

$

2,019,726

$

4,234,823

$

(2,215,097)

 

(52)%

Interest expense

 

345,371

 

323,557

 

21,814

 

7%

Gain on derivative liability

 

(816,986)

 

 

(816,986)

 

(100)%

Loss from Desert Created Investment

 

 

182,136

 

(182,136)

 

(100)%

Impairment of Desert Created Investment

 

 

823,819

 

(823,819)

 

(100)%

Gain/loss on extinguishment of debt

 

377,300

 

 

377,300

 

100%

 

$

1,925,411

$

5,564,335

$

(3,638,924)

 

(65)%


Amortization of debt discount costs generally varies with our debt balance and, in 2019, includes $318,681 of costs associated with derivative warrants from the 2019 Warrants (as defined below).  Interest expense varied between 2019 and 2018 due to the payoff of the 12% Notes in January 2018, the payoff of the Infinity Note in February 2018, and the issuance of the 8.5% Notes in April 2018. We recognized issuance costs in relation to the  derivative warrants included in our registered direct offering in May 2019. The loss on investment in Desert Created is our 50% share of the net loss of Desert Created during the three quarters September 30, 2018.  The impairment of Desert Created occurred primarily because the agreement was priced in November 2017, however, the transaction did not close until January 2018.  In the interim, our stock price increased substantially, thus the consideration we paid, in equity instruments, was higher than the fair value of the investment received.  In October 2018, we sold our 50% interest to DNFC for cash consideration of $23,045 and, accordingly, impaired the remaining balance. The gain on warrant derivative liability reflects the change in fair value of the 2019 Warrants.


Operations Consulting and Products


 

 

Year ended December 31,

 

 

 

Percent

 

 

2019

 

2018

 

Change

 

Change

Revenues

$

3,570,909

$

1,718,507

$

1,852,402

 

108%

Costs and expenses

 

(3,372,174)

 

(1,932,598)

 

(1,439,576)

 

74%

 

$

198,735

$

(214,091)

$

412,826

 

193%


Increased revenues in 2019 primarily related to revenue from license application consulting; and an increase in product sales throughout 2019.  The higher margin is due to completed applications in the third and fourth quarters of 2019.  Costs and expenses increased in 2019 primarily due to increased product sales.


4



 

Investments


 

 

Year ended December 31,

 

 

 

Percent

 

 

2019

 

2018

 

Change

 

Change

Revenues

$

95,437

$

18,749

$

76,688

 

409%

Costs and expenses

 

(71,723)

 

 

(71,723)

 

100%

Investment in Desert Created

 

 

(1,005,955)

 

1,005,955

 

(100)%

 

$

23,714

$

(987,206)

$

1,010,920

 

(102)%


The increase in revenues in 2019 is related to three new notes receivables that were executed during 2019.  All revenue is from interest and loan origination fees related to these new notes.  The investment in Desert Created includes an $823,819 impairment charge and our share of their net loss of $182,136.

 

Non-GAAP Financial Measures


For the non-GAAP Adjusted EBITDA (Earnings (loss) Before Interest, Taxes, Depreciation and Amortization) per share-basic and diluted measures presented above, we have provided (1) the most directly comparable GAAP measure; (2) a reconciliation of the differences between the non-GAAP measure and the most directly comparable GAAP measure; (3) an explanation of why our management believes this non-GAAP measure provides useful information to investors; and (4) additional purposes for which we use this non-GAAP measure.


We believe that the disclosure of Adjusted EBITDA per share-basic and diluted provides investors with a better comparison of our period-to-period operating results. We exclude the effects of certain items from net loss per share-basic and diluted when we evaluate key measures of our performance internally, and in assessing the impact of known trends and uncertainties on our business. We also believe that excluding the effects of these items provides a more balanced view of the underlying dynamics of our business. Adjusted EBITDA per share-basic and diluted excludes the impacts of interest expense, tax expense, depreciation and amortization, gain (loss) on its derivative liability, amortization of debt discount and share-based compensation. Weighted average number of common shares outstanding - basic and diluted (adjusted) excludes the impact of shares issued in connection with share-based compensation.


Tabular reconciliations of this supplemental non-GAAP financial information to our most comparable GAAP information are contained in this Report. We present such non-GAAP supplemental financial information, as we believe such information provides additional meaningful methods of evaluating certain aspects of our operating performance from period-to-period on a basis that may not be otherwise apparent on a non-GAAP basis. This supplemental financial information should be considered in addition to, not in lieu of, our Consolidated Financial Statements.


 

 

Year ended December 31,

 

 

2019

 

2018

Net loss attributable to common stockholders

$

(14,803,639)

$

(16,973,758)

Adjustment for loss from discontinued operations

 

1,675,539

 

838,448

Loss from continuing operations attributable to common stockholders

 

(13,128,100)

 

(16,135,310)

Adjustments:

 

 

 

 

Share-based expense

 

3,966,621

 

5,995,007

Depreciation and amortization

 

115,696

 

62,443

Impairment of Desert Created investment

 

 

823,819

Amortization of debt discount and equity issuance costs

 

2,019,726

 

4,234,823

Loss on extinguishment of debt

 

377,300

 

Interest expense

 

345,371

 

323,557

Gain on warrant derivative liability

 

(816,986)

 

Loss on investment of Desert Created

 

 

182,136

Total adjustments

 

6,007,728

 

11,621,785

Adjusted EBITDA

$

(7,120,372)

$

(4,513,525)

Per share – basic and diluted:

 

 

 

 

Net loss

$

(0.39)

$

(0.49)

Adjusted EBITDA

 

(0.20)

 

(0.13)

Weighted-average shares outstanding:

 

 

 

 

Net loss

 

38,106,781

 

34,938,978

Adjusted EBITDA

 

36,222,752

 

34,297,078


5




Liquidity

 

Sources of liquidity


Our sources of liquidity include cash generated from operations, the cash exercise of common stock options and warrants, debt,  and the issuance of common stock or other equity-based instruments. We anticipate our more significant uses of resources will include funding operations, developing infrastructure, as well as potential loans, investments, and business acquisitions.


In September 2019, we completed a $1,506,000 private placement with certain accredited investors pursuant to the 2019 12% Notes and the 2019 12% Warrants”).  In July 2019, we completed a $855,000 private placement pursuant to the SBI Note.


In May 2019, we raised approximately $3 million by issuing three million shares of our common stock and three million warrants (“2019 Warrants”) to purchase shares of our common stock (together “2019 Units”) in a registered direct offering for $1.00 per 2019 Unit.  The 2019 Warrants have an exercise price of $1.30 per share and are exercisable for five years from the date of issuance.  We received cash of $2,604,355, which is net of $395,645 of issuance costs.


In April 2018, we completed a $7,500,000 private placement pursuant to a promissory note (“8.5% Notes”) and warrant purchase agreement (the “8.5% Agreement”) with certain accredited investors, bearing interest at 8.5%, with principal due May 1, 2019, and interest payable quarterly.  The proceeds were made available for general working capital purposes and acquisitions.


Sources and uses of cash


We had cash of approximately $224,994 and $8.0 million, respectively, as of and December 31, 2019 and 2018.  Our cash flows from operating, investing and financing activities were as follows:


 

 

Year ended December 31,

 

 

2019

 

2018

Net cash used in operating activities

$

(5,328,661)

$

(5,726,207)

Net cash used in investing activities

 

(753,639)

 

(568,266)

Net cash provided by (used in) financing activitie

 

(1,649,875)

 

9,214,855


Net cash used in operating activities decreased in 2019 by $397,546 compared to 2018, primarily due to reduction of expenses and personnel.  Where possible, we continue to use non-cash equity-based instruments to obtain consulting services and compensate employees.


Net cash used in investing activities in 2019 relates primarily to purchasing fixed assets, including the opening of STOA Wellness retail location.  In the 2018, we purchased fixed assets and invested in the Flowhub SAFE.


Net cash used in financing activities related to the payoff of the notes payable, offset by a capital raise in May 2019. Net cash provided by financing activities in 2018 related to the exercise of warrants and options offset by paying off debt.


Capital Resources


We have no material commitments for capital expenditures as of December 31, 2019.  Part of our growth strategy, however, is to acquire businesses.  We would fund such activity through cash on hand, the issuance of debt, common stock, warrants for our common stock or a combination thereof.


Off-balance Sheet Arrangements 


We currently have no off-balance sheet arrangements.


Critical Accounting Policies

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the amounts of revenues and expenses.  Critical accounting policies are those that require the application of management’s most difficult, subjective or complex judgments, often because of the need to make estimates about the effect of matters that are inherently uncertain and that may change in subsequent periods.  In applying these critical accounting policies, our management uses its judgment to determine the appropriate assumptions to be used in making certain estimates.  Actual results may differ from these estimates.


6



We define critical accounting policies as those that are reflective of significant judgments and uncertainties and which may potentially result in materially different results under different assumptions and conditions.  In applying these critical accounting policies, our management uses its judgment to determine the appropriate assumptions to be used in making certain estimates.  These estimates are subject to an inherent degree of uncertainty.


Purchase Accounting for Acquisitions


Acquisition of a business requires companies to record assets acquired and liabilities assumed at their respective fair market values at the date of acquisition.  Any amount of the purchase price paid that is in excess of the estimated fair value of the net assets acquired is recorded as goodwill.  We determine fair value using widely accepted valuation techniques, primarily discounted cash flows and market multiple analyses.  These types of analyses require us to make assumptions and estimates regarding industry and economic factors, the profitability of future business strategies, discount rates and cash flow.  If actual results are not consistent with our assumptions and estimates, or our assumptions and estimates change due to new information, we may be exposed to an impairment charge in the future.


Accounting for Discontinued Operations


We regularly review underperforming assets to determine if a sale or disposal might be a better way to monetize the assets.  When an asset group is considered for sale or disposal, we review the transaction to determine if or when the entity qualifies as a discontinued operation in accordance with the criteria of FASB ASC Topic 205-20 “Discontinued Operations.”  The FASB has issued authoritative guidance that raises the threshold for disposals to qualify as discontinued operations.  Under this guidance, a discontinued operation is (1) a component of an entity or group of components that have been disposed of or are classified as held for sale and represent a strategic shift that has or will have a major effect on an entity’s operations and financial results, or (2) an acquired business that is classified as held for sale on the acquisition date.


Impairment of Long-lived Assets


We periodically evaluate whether the carrying value of long-lived assets has been impaired when circumstances indicate the carrying value of those assets may not be recoverable.  The carrying amount is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset.  If the carrying value is not recoverable, the impairment loss is measured as the excess of the asset’s carrying value over its fair value.


Our impairment analyses require management to apply judgment in estimating future cash flows as well as asset fair values, including forecasting useful lives of the assets, assessing the probability of different outcomes, and selecting the discount rate that reflects the risk inherent in future cash flows. If the carrying value is not recoverable, we assess the fair value of long-lived assets using commonly accepted techniques, and may use more than one method, including, but not limited to, recent third party comparable sales and discounted cash flow models.  If actual results are not consistent with our assumptions and estimates, or our assumptions and estimates change due to new information, we may be exposed to an impairment charge in the future.


Debt with Equity-linked Features


We may issue debt that has separate warrants, conversion features, or no equity-linked attributes.


When we issue debt with warrants, we determine the value of the warrants using the Black-Scholes Option Pricing Model (“Black-Scholes”) or the Binomial Model, using the stock price on the date of issuance, the risk-free interest rate associated with the life of the debt, and the estimated volatility of our stock.  


When we issue debt with a conversion feature, we must first assess whether the conversion feature meets the requirements to be treated as a derivative.  If the conversion feature within convertible debt meets the requirements to be treated as a derivative, we estimate the fair value of the convertible debt derivative using Black-Scholes upon the date of issuance, using the stock price on the date of issuance, the risk free interest rate associated with the life of the debt, and the estimated volatility of our stock.  If the conversion feature is not treated as a derivative, we assess whether it is a beneficial conversion feature (“BCF”).  A BCF exists if the conversion price of the convertible debt instrument is less than the stock price on the commitment date.  This typically occurs when the conversion price is less than the fair value of the stock on the date the instrument was issued.  The value of a BCF is equal to the intrinsic value of the feature, the difference between the conversion price and the common stock into which it is convertible.


Equity-based Payments


We estimate the fair value of equity-based instruments issued to employees or to third parties for services or goods using Black-Scholes or the Binomial Model, which requires us to estimate the volatility of our stock and forfeiture rate.


7



Revenue Recognition


On January 1, 2018, we adopted ASC Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). The core principle of ASC 606 requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASC 606 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation.


The following five steps are applied to achieve that core principle:


·

Step 1:  Identify the contract with the customer;

·

Step 2:  Identify the performance obligations in the contract;

·

Step 3:  Determine the transaction price;

·

Step 4:  Allocate the transaction price to the performance obligations in the contract; and

·

Step 5:  Recognize revenue when the company satisfies a performance obligation.


PART IV

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES


31.1*

 

Certification pursuant to Section 302 of the Sarbanes–Oxley Act of 2002 of Principal Executive Officer

31.2*

 

Certification pursuant to Section 302 of the Sarbanes–Oxley Act of 2002 of Principal Financial and Accounting Officer

32.1*

 

Certification pursuant to Section 906 of the Sarbanes–Oxley Act of 2002 of the Principal Executive and Financial Officers


(*)   Filed herewith.




8




SIGNATURES


In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.


Signature

 

Title

 

Date

 

 

 

 

 

/s/ Steve Gutterman

 

Principal Executive Officer

 

June 22, 2020

Steve Gutterman

 

 

 

 


In accordance with the Exchange Act, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature

 

Title

 

Date

 

 

 

 

 

/s/ Steve Gutterman

 

Principal Executive Officer and Director

 

June 22, 2020

Steve Gutterman

 

 

 

 

 

 

 

 

 

/s/ Jessica Bast

 

Principal Financial and Accounting Officer

 

June 22, 2020

Jessica Bast

 

 

 

 

 

 

 

 

 

/s/ Michael Feinsod

 

Chairman of the Board of Directors

 

June 22, 2020

Michael Feinsod

 

 

 

 

 

 

 

 

 

/s/ Seth Oster

 

Director

 

June 22, 2020

Seth Oster

 

 

 

 

 

 

 

 

 

/s/ Peter Boockvar

 

Director

 

June 22, 2020

Peter Boockvar

 

 

 

 

 

 

 

 

 

/s/ Mark Green

 

Director

 

June 22, 2020

Mark Green

 

 

 

 




9


General Cannabis (QB) (USOTC:CANN)
Historical Stock Chart
From Oct 2020 to Nov 2020 Click Here for more General Cannabis (QB) Charts.
General Cannabis (QB) (USOTC:CANN)
Historical Stock Chart
From Nov 2019 to Nov 2020 Click Here for more General Cannabis (QB) Charts.